About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 210253, 20 pages
http://dx.doi.org/10.1155/2013/210253
Research Article

Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

1Center for Computational Biology and Bioinformatics and College of Engineering, Koç University, Rumelifeneri Yolu, Sariyer, 34450 Istanbul, Turkey
2Department of Genetics, Institute for Experimental Medicine (DETAE), Istanbul University, 34393 Istanbul, Turkey

Received 29 April 2013; Accepted 4 June 2013

Academic Editor: Tao Huang

Copyright © 2013 Emine Guven Maiorov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Graux, J. Cools, L. Michaux, P. Vandenberghe, and A. Hagemeijer, “Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast,” Leukemia, vol. 20, no. 9, pp. 1496–1510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Van Vlierberghe, R. Pieters, H. B. Beverloo, and J. P. P. Meijerink, “Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia,” British Journal of Haematology, vol. 143, no. 2, pp. 153–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Aifantis, E. Raetz, and S. Buonamici, “Molecular pathogenesis of T-cell leukaemia and lymphoma,” Nature Reviews Immunology, vol. 8, no. 5, pp. 380–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. J. T. Staal and A. W. Langerak, “Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia,” Haematologica, vol. 93, no. 4, pp. 493–497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Ferrando, D. S. Neuberg, J. Staunton et al., “Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia,” Cancer Cell, vol. 1, no. 1, pp. 75–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Espinosa, S. Cathelin, T. D'Altri et al., “The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia,” Cancer Cell, vol. 18, no. 3, pp. 268–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Hoang and T. Hoang, “The T-ALL paradox in cancer,” Nature Medicine, vol. 16, no. 11, pp. 1185–1186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Haferlach, W. Kern, S. Schnittger, and C. Schoch, “Modern diagnostics in acute leukemias,” Critical Reviews in Oncology/Hematology, vol. 56, no. 2, pp. 223–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Haferlach, A. Kohlmann, S. Schnittger et al., “Global approach to the diagnosis of leukemia using gene expression profiling,” Blood, vol. 106, no. 4, pp. 1189–1198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. R. Golub, D. K. Slonim, P. Tamayo et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, vol. 286, no. 5439, pp. 531–537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. Nibbe and M. R. Chance, “Approaches to biomarkers in human colorectal cancer: looking back, to go forward,” Biomarkers in Medicine, vol. 3, no. 4, pp. 385–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-Y. Chuang, E. Lee, Y.-T. Liu, D. Lee, and T. Ideker, “Network-based classification of breast cancer metastasis,” Molecular Systems Biology, vol. 3, article 140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kohlmann, T. J. Kipps, L. Z. Rassenti et al., “An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the microarray Innovations in Leukemia study prephase,” British Journal of Haematology, vol. 142, no. 5, pp. 802–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. J. Wouters, B. Löwenberg, and R. Delwel, “A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects,” Blood, vol. 113, no. 2, pp. 291–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Haferlach, A. Kohlmann, L. Wieczorek et al., “Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the international microarray innovations in leukemia study group,” Journal of Clinical Oncology, vol. 28, no. 15, pp. 2529–2537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ben-Dor, L. Bruhn, N. Friedman, I. Nachman, M. Schummer, and Z. Yakhini, “Tissue classification with gene expression profiles,” Journal of Computational Biology, vol. 7, no. 3-4, pp. 559–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Alizadeh, M. B. Elsen, R. E. Davis et al., “Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling,” Nature, vol. 403, no. 6769, pp. 503–511, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Su, B.-J. Yoon, and E. R. Dougherty, “Accurate and reliable cancer classification based on probabilistic inference of pathway activity,” PLoS One, vol. 4, no. 12, p. e8161, 2009. View at Scopus
  19. S. Ramaswamy, K. N. Ross, E. S. Lander, and T. R. Golub, “A molecular signature of metastasis in primary solid tumors,” Nature Genetics, vol. 33, no. 1, pp. 49–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Ideker, V. Thorsson, A. F. Siegel, and L. E. Hood, “Testing for differentially-expressed genes by maximum-likelihood analysis of microarray data,” Journal of Computational Biology, vol. 7, no. 6, pp. 805–817, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Jansen, D. Greenbaum, and M. Gerstein, “Relating whole-genome expression data with protein-protein interactions,” Genome Research, vol. 12, no. 1, pp. 37–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Raser and E. K. O'Shea, “Molecular biology—noise in gene expression: origins, consequences, and control,” Science, vol. 309, no. 5743, pp. 2010–2013, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. V. M. Aris, M. J. Cody, J. Cheng et al., “Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer,” BMC Bioinformatics, vol. 5, article 185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Klebanov and A. Yakovlev, “How high is the level of technical noise in microarray data?” Biology Direct, vol. 2, article 9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Tu, G. Stolovitzky, and U. Klein, “Quantitative noise analysis for gene expression microarray experiments,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14031–14036, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Chen and B. Yuan, “Detecting functional modules in the yeast protein-protein interaction network,” Bioinformatics, vol. 22, no. 18, pp. 2283–2290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Gersten, M. Alirezaei, M. C. G. Marcondes et al., “An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction,” Journal of Neuroscience, vol. 29, no. 40, pp. 12467–12476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Segal, H. Wang, and D. Koller, “Discovering molecular pathways from protein interaction and gene expression data,” Bioinformatics, vol. 19, no. 1, pp. i264–i272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Ideker, O. Ozier, B. Schwikowski, and A. F. Siegel, “Discovering regulatory and signalling circuits in molecular interaction networks,” Bioinformatics, vol. 18, no. 1, pp. S233–S240, 2002. View at Scopus
  30. Y.-Q. Qiu, S. Zhang, X.-S. Zhang, and L. Chen, “Detecting disease associated modules and prioritizing active genes based on high throughput data,” BMC Bioinformatics, vol. 11, article 26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Aderem, “Systems biology: its practice and challenges,” Cell, vol. 121, no. 4, pp. 511–513, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Gu, Y. Chen, S. Li, and Y. Li, “Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis,” BMC Systems Biology, vol. 4, article 47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Vidal, “A biological atlas of functional maps,” Cell, vol. 104, no. 3, pp. 333–339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. Ş. Nacu, R. Critchley-Thorne, P. Lee, and S. Holmes, “Gene expression network analysis and applications to immunology,” Bioinformatics, vol. 23, no. 7, pp. 850–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Chen, J. Xuan, R. B. Riggins, Y. Wang, and R. Clarke, “Identifying protein interaction subnetworks by a bagging Markov random field-based method,” Nucleic Acids Research, vol. 41, article e42, 2013.
  36. A. Ergün, C. A. Lawrence, M. A. Kohanski, T. A. Brennan, and J. J. Collins, “A network biology approach to prostate cancer,” Molecular Systems Biology, vol. 3, article 82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Hwang, Z. Tian, R. Kuang, and J.-P. Kocher, “Learning on weighted hypergraphs to integrate protein interactions and gene expressions for cancer outcome prediction,” in Proceedings of the 8th IEEE International Conference on Data Mining (ICDM '08), pp. 293–302, Pisa, Italy, December 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Lage, E. O. Karlberg, Z. M. Størling et al., “A human phenome-interactome network of protein complexes implicated in genetic disorders,” Nature Biotechnology, vol. 25, no. 3, pp. 309–316, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Lee, H.-Y. Chuang, J.-W. Kim, T. Ideker, and D. Lee, “Inferring pathway activity toward precise disease classification,” PLoS Computational Biology, vol. 4, no. 11, Article ID e1000217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Rapaport, A. Zinovyev, M. Dutreix, E. Barillot, and J.-P. Vert, “Classification of microarray data using gene networks,” BMC Bioinformatics, vol. 8, article 35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. I. W. Taylor, R. Linding, D. Warde-Farley et al., “Dynamic modularity in protein interaction networks predicts breast cancer outcome,” Nature Biotechnology, vol. 27, no. 2, pp. 199–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Staiger, S. Cadot, R. Kooter et al., “A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer,” PLoS One, vol. 7, no. 4, Article ID e34796, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Chang, T. Xu, Y. Li, and K. Wang, “Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of “date” and “party” hubs,” Scientific Reports, vol. 3, article 1691, 2013. View at Publisher · View at Google Scholar
  45. J. D. Han, N. Bertin, T. Hao et al., “Evidence for dynamically organized modularity in the yeast protein-protein interaction network,” Nature, vol. 430, pp. 88–93, 2004. View at Publisher · View at Google Scholar
  46. A. Bhattacharjee, W. G. Richards, J. Staunton et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 24, pp. 13790–13795, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. W.-M. Liu, R. Li, J. Z. Sun et al., “PQN and DQN: algorithms for expression microarrays,” Journal of Theoretical Biology, vol. 243, no. 2, pp. 273–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. T. S. Keshava Prasad, R. Goel, K. Kandasamy et al., “Human protein reference database—2009 update,” Nucleic Acids Research, vol. 37, no. 1, pp. D767–D772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Hall, E. Frank, G. Holmes, B. Pfahringer, P. Reutemann, and I. H. Witten, “The WEKA data mining software: an update,” SIGKDD Explorations, vol. 11, no. 1, pp. 10–18, 2009.
  51. R. Shamir, A. Maron-Katz, A. Tanay et al., “EXPANDER—an integrative program suite for microarray data analysis,” BMC Bioinformatics, vol. 6, article 232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. P. H. Wiernik and American Cancer Society, Adult Leukemias, BC Decker, Lewiston, NY, USA, 2001.
  54. C. Sawyers, “Targeted cancer therapy,” Nature, vol. 432, no. 7015, pp. 294–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. I. B. Weinstein and A. K. Joe, “Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy,” Nature Clinical Practice Oncology, vol. 3, no. 8, pp. 448–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. K. De Keersmaecker, C. Graux, M. D. Odero et al., “Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32),” Blood, vol. 105, no. 12, pp. 4849–4852, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Graux, J. Cools, C. Melotte et al., “Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia,” Nature Genetics, vol. 36, no. 10, pp. 1084–1089, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Mori, A. M. Krensky, K. Ohshima et al., “Elevated expression of CCL5/RANTES in adult T-cell leukemia cells: possible transactivation of the CCL5 gene by human T-cell leukemia virus type I tax,” International Journal of Cancer, vol. 111, no. 4, pp. 548–557, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. M. N. Dworzak, G. Fröschl, D. Printz et al., “CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease,” Leukemia, vol. 18, no. 4, pp. 703–708, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. K. De Keersmaecker, P. Marynen, and J. Cools, “Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia,” Haematologica, vol. 90, no. 8, pp. 1116–1127, 2005. View at Scopus
  61. S. Chiaretti, M. Messina, S. Tavolaro, and R. Foa, “Myeloid/T-cell acute lymphoblastic leukemia in children and adults,” Pediatric Reports, vol. 3, supplement 2, article e3, 2011.
  62. B. Xu, X. Song, N. C. Yip et al., “Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia,” Hematology, vol. 15, no. 2, pp. 74–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Yagyu, R. Hamamoto, Y. Furukawa, H. Okabe, T. Yamamura, and Y. Nakamura, “Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma,” International journal of oncology, vol. 20, no. 6, pp. 1173–1178, 2002. View at Scopus
  64. R. D. Blumenthal, E. Leon, H. J. Hansen, and D. M. Goldenberg, “Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers,” BMC Cancer, vol. 7, article 2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Wang, S. Klumpp, H. M. Amin et al., “SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability,” Oncogene, vol. 29, no. 21, pp. 3044–3053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. V. G. Oehler, Y. Y. Ka, Y. E. Choi, R. E. Bumgarner, A. E. Raftery, and J. P. Radich, “The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data,” Blood, vol. 114, no. 15, pp. 3292–3298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Soulier, E. Clappier, J.-M. Cayuela et al., “HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL),” Blood, vol. 106, no. 1, pp. 274–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Ovaa, B. M. Kessler, U. Rolén, H. L. Ploegh, and M. G. Masucci, “Activity-based ubiquitin-specific protease (USP), profiling of virus-infected and malignant human cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2253–2258, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Ge and M. T. Elghetany, “CD36: a multiligand molecule,” Laboratory Hematology, vol. 11, no. 1, pp. 31–37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. Y.-Y. Mo and S. J. Moschos, “Targeting Ubc9 for cancer therapy,” Expert Opinion on Therapeutic Targets, vol. 9, no. 6, pp. 1203–1216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Martini, R. La Starza, H. Janssen et al., “Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia,” Cancer Research, vol. 62, no. 19, pp. 5408–5412, 2002. View at Scopus
  72. C. S. Moreno, “The sex-determining region Y-Box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways,” American Journal of Pathology, vol. 176, no. 2, pp. 518–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Strehl, A. Borkhardt, R. Slany, U. E. Fuchs, M. König, and O. A. Haas, “The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21),” Oncogene, vol. 22, no. 1, pp. 157–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Adinolfi, L. Melchiorri, S. Falzoni et al., “P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia,” Blood, vol. 99, no. 2, pp. 706–708, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Cabrini, S. Falzoni, S. L. Forchap et al., “A His-155 to tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes,” Journal of Immunology, vol. 175, no. 1, pp. 82–89, 2005. View at Scopus
  76. J. S. Wiley, L. P. Dao-Ung, B. J. Gu et al., “A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study,” Lancet, vol. 359, no. 9312, pp. 1114–1119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. C. O. Souza, G. F. Santoro, V. R. Figliuolo et al., “Extracellular ATP induces cell death in human intestinal epithelial cells,” Biochimica et Biophysica Acta, vol. 1820, pp. 1867–1878, 2012.
  78. U. Thunberg, G. Tobin, A. Johnson et al., “Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia,” Lancet, vol. 360, no. 9349, pp. 1935–1939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. E. Vacchelli, L. Galluzzi, V. Rousseau et al., “Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer,” Oncoimmunology, vol. 1, pp. 271–278, 2012.
  80. E. Adinolfi, M. G. Callegari, M. Cirillo et al., “Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis,” Journal of Biological Chemistry, vol. 284, no. 15, pp. 10120–10128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Adinolfi, L. Raffaghello, A. L. Giuliani et al., “Expression of P2X7 receptor increases in vivo tumor growth,” Cancer Research, vol. 72, pp. 2957–2969, 2012.
  82. X.-J. Zhang, G.-G. Zheng, X.-T. Ma et al., “Expression of P2X7 in human hematopoietic cell lines and leukemia patients,” Leukemia Research, vol. 28, no. 12, pp. 1313–1322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Rösmann, D. Hahn, D. Lottaz, M. N. Kruse, W. Stöcker, and E. E. Sterchi, “Activation of human meprin-α in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system,” Journal of Biological Chemistry, vol. 277, no. 43, pp. 40650–40658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Ranson and N. M. Andronicos, “Plasminogen binding and cancer: promises and pitfalls,” Frontiers in Bioscience, vol. 8, pp. s294–s304, 2003. View at Scopus
  85. J. S. Bond, G. L. Matters, S. Banerjee, and R. E. Dusheck, “Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer,” FEBS Letters, vol. 579, no. 15, pp. 3317–3322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Lottaz, C. A. Maurer, A. Noël et al., “Enhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer,” PLoS One, vol. 6, no. 11, Article ID e26450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. E. E. Sterchi, W. Stöcker, and J. S. Bond, “Meprins, membrane-bound and secreted astacin metalloproteinases,” Molecular Aspects of Medicine, vol. 29, no. 5, pp. 309–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Ishihara, C. Nishida, Y. Tashiro et al., “Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+ /F4/80+ myeloid cell recruitment,” Leukemia, vol. 26, no. 2, pp. 332–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. M. O. Khan and M. H. Ather, “Chromogranin A—serum marker for prostate cancer,” Journal of the Pakistan Medical Association, vol. 61, no. 1, pp. 108–111, 2011. View at Scopus
  90. O. Louthan, “Chromogranin a in physiology and oncology,” Folia Biologica, vol. 57, pp. 173–181, 2011.
  91. K. Jurianz, S. Ziegler, H. Garcia-Schüler et al., “Complement resistance of tumor cells: basal and induced mechanisms,” Molecular Immunology, vol. 36, no. 13-14, pp. 929–939, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Paas, O. Bohana-Kashtan, and Z. Fishelson, “Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells,” Immunopharmacology, vol. 42, no. 1–3, pp. 175–185, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Schlesinger, I. Broman, and G. Lugassy, “The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives,” Leukemia, vol. 10, no. 9, pp. 1509–1513, 1996. View at Scopus
  94. A. P. Gilmore and L. H. Romer, “Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation,” Molecular Biology of the Cell, vol. 7, no. 8, pp. 1209–1224, 1996. View at Scopus
  95. L. J. Jarvis, J. E. Maguire, and T. W. LeBien, “Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells,” Blood, vol. 90, no. 4, pp. 1626–1635, 1997. View at Scopus
  96. S. Ozkal, J. C. Paterson, S. Tedoldi et al., “Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues,” Pathology Research and Practice, vol. 205, no. 11, pp. 781–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. P. J. Reddig and R. L. Juliano, “Clinging to life: cell to matrix adhesion and cell survival,” Cancer and Metastasis Reviews, vol. 24, no. 3, pp. 425–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. V. Gabarra-Niecko, M. D. Schaller, and J. M. Dunty, “FAK regulates biological processes important for the pathogenesis of cancer,” Cancer and Metastasis Reviews, vol. 22, no. 4, pp. 359–374, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. G. W. McLean, N. O. Carragher, E. Avizienyte, J. Evans, V. G. Brunton, and M. C. Frame, “The role of focal-adhesion kinase in cancer—a new therapeutic opportunity,” Nature Reviews Cancer, vol. 5, no. 7, pp. 505–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Y. Gordon, C. R. Dowding, G. P. Riley, J. M. Goldman, and M. F. Greaves, “Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukemia,” Nature, vol. 328, no. 6128, pp. 342–344, 1987. View at Scopus
  101. M. Takahashi, A. Keating, and J. W. Singer, “A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures,” Experimental Hematology, vol. 13, no. 9, pp. 926–931, 1985. View at Scopus
  102. A. Witkiewicz-Kucharczyk and W. Bal, “Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis,” Toxicology Letters, vol. 162, no. 1, pp. 29–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. S. N. Loh, “The missing Zinc: P53 misfolding and cancer,” Metallomics, vol. 2, no. 7, pp. 442–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. E. Mocchegiani, L. Costarelli, R. Giacconi, C. Cipriano, E. Muti, and M. Malavolta, “Zinc-binding proteins (metallothionein and α-2 macroglobulin) and immunosenescence,” Experimental Gerontology, vol. 41, no. 11, pp. 1094–1107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. G. Şahin, U. Ertem, F. Duru, D. Birgen, and N. Yüksek, “High prevalence of chronic magnesium deficiency in T cell lymphoblastic leukemia and chronic zinc deficiency in children with acute lymphoblastic leukemia and malignant lymphoma,” Leukemia and Lymphoma, vol. 39, no. 5-6, pp. 555–562, 2000. View at Scopus
  106. G. A. Eby, “Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation—a case history and hypothesis,” Medical Hypotheses, vol. 64, no. 6, pp. 1124–1126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. S. T. Martin, N. Sato, S. Dhara et al., “Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms,” Cancer Biology and Therapy, vol. 4, no. 7, pp. 728–733, 2005. View at Scopus
  108. R. P. Young, C. F. Whittington, R. J. Hopkins et al., “Chromosome 4q31 locus in COPD is also associated with lung cancer,” European Respiratory Journal, vol. 36, no. 6, pp. 1375–1382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. M. H. Shahi, M. Afzal, S. Sinha et al., “Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples,” Journal of Neuro-Oncology, vol. 103, no. 2, pp. 287–296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. C. L. Olsen, P.-P. Hsu, J. Glienke, G. M. Rubanyi, and A. R. Brooks, “Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors,” BMC Cancer, vol. 4, article 43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Tada, F. Kanai, Y. Tanaka et al., “Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma,” Clinical Cancer Research, vol. 14, no. 12, pp. 3768–3776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. L. J. Leandro-García, S. Leskelä, I. Landa et al., “Tumoral and tissue-specific expression of the major human β-tubulin isotypes,” Cytoskeleton, vol. 67, no. 4, pp. 214–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. S. Yin, R. Bhattacharya, and F. Cabral, “Human mutations that confer paclitaxel resistance,” Molecular Cancer Therapeutics, vol. 9, no. 2, pp. 327–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Okada, Q. Jiang, M. Lemieux, L. Jeannotte, L. Su, and Y. Zhang, “Leukaemic transformation by CALM-AF10 involves upregulation of HOXA5 by hDOT1L,” Nature Cell Biology, vol. 8, no. 9, pp. 1017–1024, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. W. A. Dik, W. Brahim, C. Braun et al., “CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes,” Leukemia, vol. 19, no. 11, pp. 1948–1957, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. K. W. L. Yee, A. Hagey, S. Verstovsek et al., “Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies,” Clinical Cancer Research, vol. 11, no. 18, pp. 6615–6624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. I. Lahortiga, J. L. Vizmanos, X. Agirre et al., “NUP98 is fused to Adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15),” Cancer Research, vol. 63, no. 12, pp. 3079–3083, 2003. View at Scopus
  118. F. J. T. Staal and J. M. Sen, “The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis,” European Journal of Immunology, vol. 38, no. 7, pp. 1788–1794, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Kanehisa and S. Goto, “KEGG: Kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000. View at Scopus
  120. E. F. Petricoin III, V. E. Bichsel, V. S. Calvert et al., “Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy,” Journal of Clinical Oncology, vol. 23, no. 15, pp. 3614–3621, 2005. View at Publisher · View at Google Scholar · View at Scopus